- Home
- CPRX vs CSQ Comparison
CPRX vs CSQ Comparison
Compare CPRX & CSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- CSQ
- Stock Information
- Founded
- CPRX 2002
- CSQ 2003
- Country
- CPRX United States
- CSQ United States
- Employees
- CPRX N/A
- CSQ N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- CSQ Finance Companies
- Sector
- CPRX Health Care
- CSQ Finance
- Exchange
- CPRX Nasdaq
- CSQ Nasdaq
- Market Cap
- CPRX 2.9B
- CSQ 2.8B
- IPO Year
- CPRX 2006
- CSQ N/A
- Fundamental
- Price
- CPRX $20.78
- CSQ $18.18
- Analyst Decision
- CPRX Strong Buy
- CSQ
- Analyst Count
- CPRX 6
- CSQ 0
- Target Price
- CPRX $32.83
- CSQ N/A
- AVG Volume (30 Days)
- CPRX 1.4M
- CSQ 220.3K
- Earning Date
- CPRX 08-06-2025
- CSQ 01-01-0001
- Dividend Yield
- CPRX N/A
- CSQ 7.53%
- EPS Growth
- CPRX 178.13
- CSQ N/A
- EPS
- CPRX 1.57
- CSQ N/A
- Revenue
- CPRX $534,645,999.00
- CSQ N/A
- Revenue This Year
- CPRX $16.37
- CSQ N/A
- Revenue Next Year
- CPRX $8.80
- CSQ N/A
- P/E Ratio
- CPRX $13.34
- CSQ N/A
- Revenue Growth
- CPRX 29.97
- CSQ N/A
- 52 Week Low
- CPRX $15.34
- CSQ $12.50
- 52 Week High
- CPRX $26.58
- CSQ $16.45
- Technical
- Relative Strength Index (RSI)
- CPRX 38.36
- CSQ 62.47
- Support Level
- CPRX $20.62
- CSQ $18.08
- Resistance Level
- CPRX $22.10
- CSQ $18.35
- Average True Range (ATR)
- CPRX 0.60
- CSQ 0.19
- MACD
- CPRX 0.06
- CSQ -0.03
- Stochastic Oscillator
- CPRX 50.34
- CSQ 63.48
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About CSQ Calamos Strategic Total Return
Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.